[Efficacy and Safety of Venetoclax-Based Chemotherapy Regimens for High-Risk Acute Myeloid Leukemia]
{{output}}
Objective: To evaluate the efficacy and safety of venetoclax (VEN) in combination with hypomethylating agents and/or low-dose cytarabine (LDAC) in patients with relapsed or refractory (RR) or persistently positive minimal residua... ...
